Ambrx
Nick Knudsen is a Senior Director at Ambrx since January 2005. Nick has extensive experience in protein science and downstream processing, leading the development efforts for protein based therapeutics such as long acting proteins, bi-specifics, and antibody drug conjugates (ADC) using Ambrx technology. Prior to their current role, Nick has worked as a Contract Scientist at Celgene and as an Associate Scientist at Apovia, Inc. Nick holds a MS in Molecular Biology and a BS in Molecular and Cell Biology from San Diego State University.
This person is not in the org chart
Ambrx
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties.